Literature DB >> 16604847

Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program.

Denise DeRoeck1, Saleh A Bawazir, Peter Carrasco, Miloud Kaddar, Alan Brooks, John Fitzsimmons, Jon Andrus.   

Abstract

This paper reviews the key design features, accomplishments of and lessons learned from two regional group procurement mechanisms dealing with vaccines that have been in operation for more than 25 years. The Pan American Health Organization (PAHO) EPI Revolving Fund purchases vaccines and immunization supplies on behalf of more than 35 countries in the Latin American and Caribbean region. Based on a 'central contracting' model, the program handles most aspects of procurement-from tendering to contracting with and paying producers--using a common fund to pay producers before being reimbursed by countries once goods are received in-country. The Gulf Cooperation Council (GCC) Group Purchasing Program among seven Persian Gulf States issues joint tenders for vaccines, as well as drugs and other medical goods. Through this 'group contracting' program, countries are responsible for contracting with and paying producers on their own, once the group has selected winning bids. Both programs have experienced substantial growth in the past two decades and are considered to have contributed to or accelerated achievements of immunization programs in both regions, including the introduction of new vaccines. The paper identifies several features of both programs--both those designed to attract country participation and those designed to ensure the programs' financial viability--which help explain their success and longevity.

Mesh:

Substances:

Year:  2006        PMID: 16604847     DOI: 10.1002/hpm.822

Source DB:  PubMed          Journal:  Int J Health Plann Manage        ISSN: 0749-6753


  12 in total

1.  Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

Authors:  Lara J Wolfson; François Gasse; Shook-Pui Lee-Martin; Patrick Lydon; Ahmed Magan; Abdelmajid Tibouti; Benjamin Johns; Raymond Hutubessy; Peter Salama; Jean-Marie Okwo-Bele
Journal:  Bull World Health Organ       Date:  2008-01       Impact factor: 9.408

Review 2.  Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia.

Authors:  E Anthony S Nelson; Ciro A de Quadros; Mathuram Santosham; Umesh D Parashar; Duncan Steele
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

3.  Medicine shortages in Fiji: A qualitative exploration of stakeholders' views.

Authors:  Josephine Walker; Betty B Chaar; Numa Vera; Alvish S Pillai; Jessy S Lim; Lisa Bero; Rebekah J Moles
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

4.  Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries.

Authors:  Gabriel Seidman; Rifat Atun
Journal:  BMJ Glob Health       Date:  2017-04-13

5.  Global rotavirus vaccine introductions and coverage: 2006 - 2016.

Authors:  Alice J Abou-Nader; Molly A Sauer; A Duncan Steele; Jacqueline E Tate; Deborah Atherly; Umesh D Parashar; Mathuram Santosham; E Anthony S Nelson
Journal:  Hum Vaccin Immunother       Date:  2018-06-18       Impact factor: 3.452

6.  Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study.

Authors:  Temmy Sunyoto; Julien Potet; Margriet den Boer; Koert Ritmeijer; Jose A R Postigo; Raffaella Ravinetto; Fabiana Alves; Albert Picado; Marleen Boelaert
Journal:  BMJ Open       Date:  2019-05-30       Impact factor: 2.692

7.  Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up.

Authors:  Rima Shretta; Prashant Yadav
Journal:  Malar J       Date:  2012-12-02       Impact factor: 2.979

8.  Progress in vaccination against Haemophilus influenzae type b in the Americas.

Authors:  M Carolina Danovaro-Holliday; Salvador Garcia; Ciro de Quadros; Gina Tambini; Jon K Andrus
Journal:  PLoS Med       Date:  2008-04-22       Impact factor: 11.069

9.  The global intellectual property ecosystem for insulin and its public health implications: an observational study.

Authors:  Warren A Kaplan; Reed F Beall
Journal:  J Pharm Policy Pract       Date:  2016-07-19

10.  Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country.

Authors:  Daniela Moye-Holz; Jitse P van Dijk; Sijmen A Reijneveld; Hans V Hogerzeil
Journal:  Global Health       Date:  2017-08-01       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.